97 related articles for article (PubMed ID: 6393976)
1. Reduced side effects by low dose of acetylsalicylic acid (ASA) in patients with myocardial infarction; estimations of serum thromboxane B2 and PGF2 alpha.
Hoffmann W; Foerster W; Mest HJ; Taube C; Block HU; Braun H
Biomed Biochim Acta; 1984; 43(8-9):S467-70. PubMed ID: 6393976
[TBL] [Abstract][Full Text] [Related]
2. [Thrombocyte aggregation and serum thromboxane in patients with acute myocardial infarction].
Midttun M; Grauholt AM; Grande P
Ugeskr Laeger; 1990 Dec; 153(1):25-6. PubMed ID: 2275044
[TBL] [Abstract][Full Text] [Related]
3. [Measurement of plasma and serum values of PGE2, PGF2 alpha and TXB2 during aspirin induced bronchospasm in asthmatics (author's transl)].
Pradalier A; Dry J; Dray F
Therapie; 1979; 34(4):467-74. PubMed ID: 531778
[No Abstract] [Full Text] [Related]
4. Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial.
Latini R; Santoro E; Masson S; Tavazzi L; Maggioni AP; Franzosi MG; Barlera S; Calvillo L; Salio M; Staszewsky L; Labarta V; Tognoni G;
Heart Dis; 2000; 2(3):185-90. PubMed ID: 11728260
[TBL] [Abstract][Full Text] [Related]
5. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
Breddin K; Loew D; Lechner K; Oberla K; Walter E
Circulation; 1980 Dec; 62(6 Pt 2):V63-72. PubMed ID: 6777073
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of acetylsalicylic acid (ASA) and sulfinpyrazone on isoproterenol-induced heart damage.
Karmazyn M; Moffat MP; Beamish RE; Dhalla NS
J Pharmacol Exp Ther; 1981 Sep; 218(3):764-70. PubMed ID: 6894943
[No Abstract] [Full Text] [Related]
7. Intravenous acetylsalicylic acid--dose-related effects on platelet function and fibrinolysis in healthy males.
Husted SE; Kristensen SD; Vissinger H; Mørn B; Schmidt EB; Nielsen HK
Thromb Haemost; 1992 Aug; 68(2):226-9. PubMed ID: 1412171
[TBL] [Abstract][Full Text] [Related]
8. The absorption of acetylsalicylic acid from an enteric-coated formulation and the inhibition of thromboxane formation.
Anttila M; Kahela P; Uotila P
Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):88-92. PubMed ID: 3410591
[TBL] [Abstract][Full Text] [Related]
9. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
Dale J; Thaulow E; Myhre E; Parry J
Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
[TBL] [Abstract][Full Text] [Related]
10. Chronic aspirin treatment affects collagen deposition in non-infarcted myocardium during remodeling after coronary artery ligation in the rat.
Kalkman EA; van Suylen RJ; van Dijk JP; Saxena PR; Schoemaker RG
J Mol Cell Cardiol; 1995 Nov; 27(11):2483-94. PubMed ID: 8596199
[TBL] [Abstract][Full Text] [Related]
11. Effect of cytostatics on prostaglandin F2 alpha prostacyclin, and thromboxane in patients with gynecologic malignancies.
Ylikorkala O; Kauppila A; Viinikka L
Obstet Gynecol; 1981 Oct; 58(4):483-6. PubMed ID: 7024882
[TBL] [Abstract][Full Text] [Related]
12. [Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke].
Oláh L; Misz M; Bereczki D; Fekete I; Bordánné JE; Takács EI
Orv Hetil; 1996 Mar; 137(9):455-9. PubMed ID: 8714038
[TBL] [Abstract][Full Text] [Related]
13. Partial inhibition of platelet thromboxane A2 synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myocardial infarction.
Valles J; Santos MT; Fuset MP; Moscardo A; Ruano M; Perez F; Piñon M; Breña S; Aznar J
Am J Cardiol; 2007 Jan; 99(1):19-25. PubMed ID: 17196455
[TBL] [Abstract][Full Text] [Related]
14. Increased platelet aggregation and serum thromboxane levels in aspirin-treated patients with prior myocardial infarction.
Larsen SB; Neergaard-Petersen S; Grove EL; Kristensen SD; Hvas AM
Thromb Haemost; 2012 Jul; 108(1):140-7. PubMed ID: 22534977
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
[TBL] [Abstract][Full Text] [Related]
16. Effects of aspirin or picotamide, an antithromboxane agent, in combination with low-intensity oral anticoagulation in patients with acute myocardial infarction: a controlled randomized pilot trial.
Vetrano A; Milani M; Corsini G
G Ital Cardiol; 1999 May; 29(5):524-8. PubMed ID: 10367219
[TBL] [Abstract][Full Text] [Related]
17. Umbilical cord serum levels of thromboxane B2 in term infants of women who participated in a placebo-controlled trial of low-dose aspirin.
Parker CR; Hauth JC; Goldenberg RL; Cooper RL; Dubard MB
J Matern Fetal Med; 2000; 9(4):209-15. PubMed ID: 11048830
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunoassay of thromboxane B2 in plasma of normal and asthmatic subjects.
Morris HG; Sherman NA; Shepperdson FT; Selner JC
Adv Prostaglandin Thromboxane Res; 1980; 8():1759-64. PubMed ID: 7377023
[No Abstract] [Full Text] [Related]
19. The prevalence of intolerance for low-dose acetylsalicylacid in the secondary prevention of atherothrombosis.
Tournoij E; Peters RJ; Langenberg M; Kanhai KJ; Moll FL
Eur J Vasc Endovasc Surg; 2009 May; 37(5):597-603. PubMed ID: 19297216
[TBL] [Abstract][Full Text] [Related]
20. Plasma thromboxane B2 levels and atherosclerotic disorders.
Numano F; Omori K; Nishiyama K; Kishi Y; Shimokado K; Numano F; Yajima M; Maezawa H
Paroi Arterielle; 1981; 7(3):99-105. PubMed ID: 6122194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
